THERAPEUTIC AGENT TREATMENT

Brand Owner (click to sort) Address Description
&DNA Son, In Sik 304-1104, 72, Jeongjail-ro, Bundang-gu, Seongnam-si Gyeonggi-do 13614 Republic of Korea Therapeutic agent for the treatment of skin disease; Medicine for skin; Ointment for the treatment of skin disease; Therapeutic agent comprising aptamer; Medicine comprising aptamer; Medicine for skin care comprising aptamer; External preparation for the treatment of wound; Medicine for skin care for application skin;
CINGAL ANIKA THERAPEUTICS, INC. 32 Wiggins Avenue Bedford MA 01730 therapeutic agent for the treatment of jaw and articular discomfort or dysfunction;
CINGAL ANIKA THERAPEUTICS, INC. 32 Wiggins Avenue Bedford MA 01730 therapeutic agent for the treatment of articular discomfort or dysfunction;
MONOVISC ANIKA THERAPEUTICS, INC. 32 Wiggins Avenue Bedford MA 01730 therapeutic agent for the treatment of jaw and articular discomfort or dysfunction;
MONOVISC ANIKA THERAPEUTICS, INC. 32 Wiggins Avenue Bedford MA 01730 therapeutic agent for the treatment of articular discomfort or dysfunction;
TMJEL ANIKA THERAPEUTICS, INC. 32 Wiggins Avenue Bedford MA 01730 therapeutic agent for the treatment of jaw and articular discomfort or dysfunction;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides a composition containing particulate composite of a polymer and a therapeutic agent. The composition also contains a complexing agent. The polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex. A therapeutic composition of the invention may be used to deliver the therapeutic agent and to treat various disorders. Both the polymer of the particulate composite and the complexing agent may be used to introduce functionality into the therapeutic composition. The invention also relates to a method of preparing a composition. The method combines a therapeutic agent, a polymer having host or guest functionality, and a complexing agent having guest or host functionality to form the therapeutic composition. The complexing agent forms an inclusion complex with the polymer. The invention also relates to a method of delivering a therapeutic agent. According to the method, a therapeutically effective amount of a therapeutic composition of the invention is administered to a mammal (e.g. person or animal) in recognized need of the therapeutic. Also disclosed are compounds having the formula: